Gonadal shield.
A secondary gonadal shield for use in the pelvic irradiation of males was designed and built using material and apparatus available with the Cerrobend blocking system. The gonadal dose was reduced to approximately 1.5 to 2.5% of the given dose.
D006689:Hodgkin Disease / Q000532:radiotherapy; D006801:Humans; D008223:Lymphoma / Q000532:radiotherapy; D008297:Male; D011835:Radiation Protection / Q000295:instrumentation*; D011878:Radiotherapy / Q000295:instrumentation*; D013737:Testis / Q000528:radiation effects*